Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04890990 · ClinicalTrials.gov registry record · NA
Reducing Depression-related Stigma and Increasing-treatment Seeking Among Black Adolescents
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 1,291
- Enrollment target
NCT04890990: Completed NA study, sponsored by Yale University.
NCT04890990 is a NA study that has completed, run by Yale University. The registered enrollment target is 1,291 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04890990, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,291 participants
- Enrollment target
Study Summary
The purposes of this study are to: 1. test among adolescent the utility of brief video-based interventions to reduce stigma-related attitudes and increase help-seeking intentions toward depression; 2. examine the role of race (Black vs other) as an independent factor in the primary outcome.
Primary Outcome
The DSS (Christensen, Jorm, Evans, \& Groves, 2004) is a self-report instrument composed of two 9-item subscales. The first subscale measures the participants' own/ personal attitudes, and the second measures participants' beliefs about the attitudes of others ('Depression is sign of weakness' vs. 'Most people believe that depression is a sign of weakness'). We will use the Personal subscale (DSS-Personal) in this study. The DSS has a 5-point Likert scale ranging from strongly disagree (1) to st
Interventions
- BEHAVIORAL Short videos
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,291 participants |
| Start Date | 2021-07-15 |
| Est. Completion | 2021-08-07 |
| Phase | NA |
What the finished NCT04890990 record still lists
NCT04890990 is an interventional study that assigns participants to a tested intervention. Its 1,291 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 1 intervention - of which Short videos is the first listed.
NCT04890990 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04890990 about?
NCT04890990 is a clinical study titled "Reducing Depression-related Stigma and Increasing-treatment Seeking Among Black Adolescents". The purposes of this study are to: 1. test among adolescent the utility of brief video-based interventions to reduce stigma-related attitudes and increase help-seeking intentions toward depression; 2. examine the role of race (Black vs other) as an independent factor in the primary outcome.
What is the current status of trial NCT04890990?
This trial is currently completed. It is a NA study. The enrollment target is 1,291 participants. The study started on 2021-07-15. Estimated completion is 2021-08-07.
What interventions are being tested in trial NCT04890990?
The interventions under investigation include: Short videos (BEHAVIORAL).
Who is sponsoring clinical trial NCT04890990?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04890990's enrollment target sits among peer trials
1,291 78th of 2000 higher than 1,923 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05595642 · 1,290 participants · Phase 3
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
- NCT05812807 · 1,295 participants · Phase 3
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
- NCT06626022 · 1,284 participants · Phase 3
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
- NCT04474223 · 1,300 participants · Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI